Built through research_
A scientific posture
The myBrain Tech team is convinced that Neuroscience has to meet the challenges of tomorrow’s world.
Understanding the human brain will be key in the evolution. Knowing individuals’ desires, feelings, emotions and behaviours in real-life contexts will have a tremendous impact at any levels: medical, social, environmental, business, etc.
Consisting of researchers and physicians, the team wants to provide access to the knowledge of brain science for the benefit of all.
Truth and transparency
Sincerity is in our DNA. As researchers, we strive for truth. Our scientific skills allow us to bring the expertise necessary for the success of a whole project. We are unlocking access to Neuroscience by democratizing brain analysis and spreading the use of brain data.
Scientifically validated _
-
International Scientific & Clinical Board
10 internationally renown experts support our R&D activities.
Their broad expertise covers any knowledge in Applied and Clinical Neuroscience, Brain-Computer Interfaces, Artificial Intelligence, Cognitive Science, Psychology, Psychiatry. -
A unique IP
myBrain Tech counts 30+ national and international patents and own fully the IP of the solutions deployed on the market. -
Scientific Evidence
Science First ! We count 20+ scientific publications.
Our solutions rely on a rigorous scientific validation before entering the market.
Healthy Business relies on good science.
-
At the core of the brain!
We were born as a spin-off of the prestigious Brain Institute of Paris at the 'Pitié-Salpetriere Hospital'.
A vibrant and passionate community of researchers, clinicians and developers accelerated our growth, 7 years ago.
Our mission is to enhance Technologies through AI enriched by neurosciences. Join us to bridge the gap between Human and Digital!
Yohan Attal is co-founder and CEO of myBrain Technologies. Yohan holds a PhD in Brain Imaging and Signal Processing from the Orsay Faculty of Science at the University of Paris XI. Yohan applies his scientific expertise and business knowledge to commercialise the latest neuroscience discoveries on the global market.
